• The RIDD study team based at Oxford
  • Clinical examination of Dupuytren's contracture
  • Completing questionnaires on hand function and health
  • Measuring how well fingers can straighten and bend
  • Measuring skin hardness over a Dupuytren's nodule
  • Ultrasound imaging of a Dupuytren's nodule and cord
  • Measuring hand grip strength
  • Separating the Dupuytren's nodule and cord which have been removed from a patient during usual surgery
  • Removed Dupuytren's nodule tissue is analysed in our lab in Oxford

We need you - help us beat Dupuytren's disease!

We are working hard to discover a treatment for early stage Dupuytren's disease.

Currently, there is no approved treatment for early stage Dupuytren's disease.  Instead, patients are left to watch their hands deteriorate until it is time to have corrective surgery. Data from our lab show that anti-TNF -  a drug used to treat other inflammatory conditions - works on diseased tissue from patients with Dupuytren's disease. 

Based on a positive signal from the first part of our study, we are now working on the next stage of our research: a randomised trial of anti-TNF treatment for early stage Dupuytren's disease.

Developing a treatment for early Dupuytren's disease

NEWS: We've won an award!

We are delighted to have been chosen as the winner of the International Dupuytren Award 2019 for our publication of the results of part 1 of the RIDD trial